W. van den Berg

Ifn Amplification Loop Tlr4 and Tlr7/8 by Abrogating the Type I Tlr2 Promotes Th2/th17 Responses Via

R. Huijbens, E. Lubberts, S. Abdollahi-Roodsaz, 2022 .

IL-17 produced by Paneth cells drives TNF-induced shock

R. De Rycke, A. Cauwels, I. Vanlaere, 2008, The Journal of experimental medicine.

Functional consequences of DECTIN-1 early stop codon polymorphism Y238X in rheumatoid arthritis

L. Joosten, J. Fransen, T. Plantinga, 2010, Arthritis research & therapy.

Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.

L. Joosten, W. B. van den Berg, L. Joosten, 1996 .

Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.

L. Joosten, W. B. van den Berg, E. Lubberts, 2004, Arthritis and rheumatism.

Functional consequences of DECTIN-1 early stop codon polymorphism Y238X in rheumatoid arthritis

L. Joosten, M. Netea, P. V. van Riel, 2010, Arthritis research & therapy.

IL-17 produced by Paneth cells drives TNF-induced shock

L. Joosten, C. Libert, R. De Rycke, 2008, The Journal of experimental medicine.

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis

L. Joosten, D. Heinegård, W. B. van den Berg, 1999, Arthritis research.

Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators.

W. B. van den Berg, F. V. D. van de Loo, W. van den Berg, 2002, Rheumatic diseases clinics of North America.